← Open Payments lookup

WENDY TOWNLEY: Open Payments

NPI 1730507591 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,657 in 18 payments from 13 companies in 2025. Trend: 2023 $842 · 2024 $850 · 2025 $1,657

Food & beverage: $1,657
CompanyPaymentsAmount
ABBVIE INC.2$250
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$230
Axsome Therapeutics, Inc.3$182
Novo Nordisk Inc2$148
KYOWA KIRIN, INC.1$130
Amgen Inc.1$129
Lilly USA, LLC1$125
Ardelyx, Inc.1$124
AstraZeneca Pharmaceuticals LP1$121
PFIZER INC.1$94

Products named: VRAYLAR, XIFAXAN, Auvelity, REPATHA, Ozempic, MOUNJARO, IBSRELA, AIRSUPRA.

Industry payments across LA — which companies pay providers there.